Exam 3 Review Flashcards
Osteoarthritis definition
Degeneration of articular cartilage with hypertrophy of contiguous bone: joint space loss, subchondral cysts, sclerosis, osteophytes
Osteoarthritis joint involvement
DIP (Heberden’s), PIP (Bouchard’s), 1st CMC
Hips and knees
Spine: cervical and lumbar
First MTP
Osteoarthritis predisposing factors
Age, obesity, occupational risks (miners, weavers), trauma
Secondary OA: inflammatory, metabolic (hemochromatosis, Wilson’s disease, ochronosis)
Sports in general present no increased risk; exercise may be protective
Components of cartilage
1) Collagen: predominantly type II
2) Proteoglycans (chondroitin, keratin sulfate) linked to hyaluronic acid
3) Matrix proteins: MMPs (collagenase, gelatinase, stromelysin), TIMPs
4) Chondrocytes
5) Water: 70% by weight
No nerves, blood vessels
Cartilage changes in osteoarthritis
1) Increased chondrocytes
2) Decreased proteoglycan
* 3) Increased metalloproteinases
4) Decreased TIMP
5) Increased water content
6) Lacks systemic features
Synovial fluid in osteoarthritis
Noninflammatory, type I (200-2000 WBC/mm^3)
Cytokines/inflammatory mediators in osteoarthritis
1) IL-1: stimulates MMP production, PGE2, NO, IL-6
2) NO: increases MMP prodution, inhibits proteoglycan synthesis, induces chondrocyte apoptosis
3) Prostaglandins: increase production/activation of MMPs
4) Other cytokines: TNF, IL-6, IL-17, IL-18
5) Complement activated
6) Adipokines
Radiographic findings of osteoarthritis
1) Joint space loss
2) Sclerosis (whitening)
3) Subchondral cysts
4) Osteophytes
Rheumatoid arthritis definition
Systemic, inflammatory, autoimmune disorder of unknown etiology that results in peripheral, symmetric synovitis which can result in cartilage and bone destruction
Rheumatoid arthritis joint involvement
Bilateral, symmetric
Small joints in hands and feet - but sparing the DIPs
Medium and large joints can also be involved
Radiographic findings of rheumatoid arthritis
Marginal joint erosions and deformities
Etiology of rheumatoid arthritis
Unknown beyond arthritogenic peptides in genetically susceptible host
Genetic susceptibility in rheumatoid arthritis
Shared epitope (QKRAA, in antigen-binding groove) In subtypes of HLA-DR4, HLA-DR1
Rheumatoid factor
IgM (sometimes IgG or IgA) antibody directed against Fc portion of IgG Present in 85% of patients with RA Not specific for RA or CTDs Produced locally in synovial tissue *RF-IgG immune complexes are pathogenic
Anti-CCP antibodies
AutoAbs reactive with synthetic peptides containing cirulline (modified arginine residue)
Specifically present in sera of RA patients: 88-99% specificity, 98-100% specific when present with RF
Occur more frequently in individuals with shared epitope - citrullination of peptides enhances binding
Lymphocytes in rheumatoid arthritis synovium
Majority are CD4+ T cells (modulation/amplification of local immune response through Ag recognition) and Th17 cells
IL-1, TNF-a
T cell cytokines (IL-2, IFN-y) are sparse
B cells and plasma cells also present
Extra-articular manifestations of rheumatoid arthritis
RF-IgG immune complex-induced vasculitis
Rheumatoid nodule formation in tissues/organs
Gout definition
Result of tissue deposition of MSU crystals due to hyperuricemia (MSU supersaturation of extracellular fluids)
Joint involvement in gout
1st MTP (podagra) Cool, peripheral joints of lower and upper extremities
2 reasons for hyperuricemia
1) Overproduction of uric acid
* 2) Underexcretion of uric acid (90% of cases)
Uric acid involvement in gout
Product of purine metabolism
Humans lack uricase - oxidizes uric acid into allantoin